Personality Predicts Placebo Effect

People with certain personality traits are more likely to get pain relief from a placebo, a finding that could help improve clinical trials.

Written byDan Cossins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Colored areas show regions of greater mu-opioid release during placebo administration in volunteers with high levels of resilience, straightforwardness and altruism, and low levels of angry hostility. Marta Pecina/University of MichiganIndividuals who are altruistic, resilient, and straightforward show greater activity in brain regions associated with reward and are more likely to enjoy pain relief when a placebo is administered during a painful experience, according to a study reported this week (November 15) in Neuropsychopharmacology. The findings suggest that simple personality tests could be used to improve the accuracy of clinical trials by identifying people likely to skew results with high placebo responses.

“This is interesting because it’s one of the first studies to look at how personality traits are associated with placebo analgesia not only in terms of subjective reports of pain relief, but also with quite solid objective measures in key parts of the brain,” said Tor Wager, a neuroscientist at the University of Boulder, Colorado, who was not involved in the study.

Placebos are known to have strong analgesic effects. In 2007, neuroscientist Jon-Kar Zubieta of the University of Michigan showed that such effects were associated with activity in the nucleus accumbens, a brain region involved in reward and pleasure. That suggested that placebo analgesia might occur in part because positive expectations of reward (pain relief) spike dopamine levels in the brain and stimulate the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies